Kindred Biosciences (KIN) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts KIN Hot Sheet
Join SI Premium – FREE
Kindred Biosciences (NASDAQ: KIN) reported Q3 EPS of ($0.29), $0.05 better than the analyst estimate of ($0.34).
For earnings history and earnings-related data on Kindred Biosciences (KIN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
- BofA Securities Downgrades Autohome Inc. (ATHM) to Underperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
